Coya Therapeutics (COYA)
Develops Treg-focused therapies for neurodegenerative and immune-mediated diseases.
$5.38
After hours+0.07 (+1.32%)
At close$5.31(+7.27%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 33.22% | 7.79M shares | |
|---|---|---|---|
| 57 holders · as of Jun 30, 2026 | |||
| Insiders | 4.93% | 1.16M shares | |
| 5 holders · as of Jan 28, 2026 | |||
| Strategic holders | 9.69% | 2.27M shares | |
| 1 holder · as of Mar 12, 2026 | |||
| Other | 52.16% | 12.23M shares | |
| remainder | |||
23.46M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
57 holders · 7.79M shares · 7 new positions · 22 increased · 16 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Dme Capital Management, LP | 2.34M | 9.96% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 842.2K | 3.59% | −2.7K | Aug 13, 2026 |
| Alyeska Investment Group, L.P. | 800.0K | 3.41% | 0 | Aug 14, 2026 |
| Aigh Capital Management LLC | 631.9K | 2.69% | −343.5K | Aug 7, 2026 |
| CM Management, LLC | 400.0K | 1.71% | +25.0K | Aug 13, 2026 |
| Private Management Group Inc | 384.2K | 1.64% | +15.1K | Jul 31, 2026 |
| Marshall Wace, LLP | 249.8K | 1.06% | +24.0K | Aug 13, 2026 |
| Geode Capital Management, LLC | 228.2K | 0.97% | −5.2K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Dr. Reddy's Laboratories, Inc. | 9.70% | 2.27M | 13G | Mar 12, 2026 |
| DME Capital Management, LP | 7.60% | 1.27M | 13G | Feb 14, 2025 |
| Orin Hirschman | 5.30% | 1.11M | 13G | Jan 28, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.